Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07001852 · ClinicalTrials.gov registry record · NA
EnDOvascular Therapy for Late WiNdow IschEmic Stroke Patients Selected bY AutoMatic Plain ComputErized Tomography
A NA study of Stroke, Acute, sponsored by Santiago Ortega Gutierrez.
- Recruiting
- Registry status
- NA
- Development phase
- 500
- Enrollment target
- 2
- Study locations
NCT07001852 is a NA study of Stroke, Acute that is actively recruiting participants, run by Santiago Ortega Gutierrez. The registered enrollment target is 500 participants, below the 610-participant average among 25 other Stroke, Acute trials with a reported enrollment target (18% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT07001852, a NA study of Stroke, Acute, is actively recruiting participants, sponsored by Santiago Ortega Gutierrez.
- RECRUITING
- Registry status
- NA
- Development phase
- 500 participants
- Enrollment target
- 2
- Study locations
Study Summary
The DONE SYMPLE Investigator-initiated phase III prospective, randomized, open-label, blinded endpoint-controlled clinical trial. This clinical trial is a global clinical study testing whether a procedure called endovascular therapy, which removes blood clots from blocked brain arteries, can safely benefit more stroke patients when used up to 72 hours after symptoms begin. Endovacular Therapy is already proven to improve recovery in patients treated within 6 hours, but only when advanced imaging like Computed Tomography (CT) perfusion or Magnetic Resonance Imaging (MRI) is available to guide treatment. Unfortunately, many hospitals, specially in underserved areas, do not have access to this type of imaging. This trial will investigate whether a basic brain scan called non-contrast CT, which is widely available in hospitals around the world, can be used instead. Special software will automatically analyze the CT scan to help doctors decide if a patient has enough brain tissue left to save with Endovascular Therapy. If this simpler approach works, it could expand access to lifesaving stroke care for more people globally. The study will enroll 500 adult stroke patients, ages 18 to 80, with a large vessel blockage in the brain's anterior circulation, moderate to severe stroke symptoms, and who are between 6 and 72 hours from when they were last known to be well. All participants will undergo CT imaging analyzed by the automated software. If the scan shows a small core of already damaged brain tissue and a larger area of threatened but still viable brain, the patient will qualify. Participants will be randomly assigned to receive either standard medical therapy alone or medical therapy plus Endovasculat Therapy which involves inserting a catheter through a blood vessel to reach the brain and using a device to remove the clot. This procedure is performed by trained stroke or neurointerventional specialists. The study is "open-label," meaning patients and doctors know
Conditions Studied
Interventions
- OTHER Endovascular Therapy (Mechanical Thrombectomy)
- OTHER Standard Medical Management
Study Locations (2)
Iowa
- University of Iowa - Iowa City
Other
- Erebouni Medical Center - Yerevan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2025-10-14 |
| Est. Completion | 2029-07-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07001852
The ClinicalTrials.gov registry entry for NCT07001852 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 610-participant average among 25 other Stroke, Acute trials with a reported enrollment target (18% lower). The listed sponsor is Santiago Ortega Gutierrez, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Stroke, Acute appearing as the primary indexed condition, and to 2 interventions - of which Endovascular Therapy (Mechanical Thrombectomy) is the first listed.
NCT07001852 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Iowa, Other.
Frequently Asked Questions
What is clinical trial NCT07001852 about?
NCT07001852 is a clinical study titled "EnDOvascular Therapy for Late WiNdow IschEmic Stroke Patients Selected bY AutoMatic Plain ComputErized Tomography". The DONE SYMPLE Investigator-initiated phase III prospective, randomized, open-label, blinded endpoint-controlled clinical trial. This clinical trial is a global clinical study testing whether a procedure called endovascular therapy, which removes blood clots from blocked brain arteries, can safely...
What is the current status of trial NCT07001852?
This trial is currently recruiting. It is a NA study. The enrollment target is 500 participants. The study started on 2025-10-14. Estimated completion is 2029-07-01.
What conditions does trial NCT07001852 study?
This clinical trial studies the following conditions: Stroke, Acute.
What interventions are being tested in trial NCT07001852?
The interventions under investigation include: Endovascular Therapy (Mechanical Thrombectomy) (OTHER), Standard Medical Management (OTHER).
Who is sponsoring clinical trial NCT07001852?
This trial is sponsored by Santiago Ortega Gutierrez, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07001852 being conducted?
This trial has 2 study locations across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke, Acute
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
WE-TRUST (Workflow Optimization to Reduce Time to Endovascular Reperfusion for Ultra-fast Stroke Treatment)
RECRUITING · NA
-
Wearable MCI to Reduce Muscle Co-activation in Acute and Chronic Stroke
RECRUITING · NA
-
Delay AvoIding Primary Evaluation for ThRombectomy of Acute StrokE Patients With Large Vessel OCclusion in the Angiography SuiTe
RECRUITING · NA
-
Hospital Implementation of a Stroke Protocol for Emergency Evaluation and Disposition
RECRUITING · NA
-
Efficacy of a Telehealth Delivered Group Lifestyle Balance for People Post Stroke (tGLB-CVA)
RECRUITING · NA
-
ECMO ABI Detection With Hyperfine
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.